MAPS Congratulates Lykos Therapeutics on Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD
The FDA has accepted a New Drug Application filed by Lykos Therapeutics for MDMA-assisted therapy for PTSD The application was...
Day: February 10, 2024
Vision Sensing Acquisition Corp. Announces Filing of Form 10-Q with the SEC For the Quarterly Period Ended September 30, 2023, Regaining Compliance with the Filing Requirement in Nasdaq Listing Rule 5250(c)(1)
MIAMI, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose...
New Late Breaking Preliminary Data Demonstrate Balt’s Squid™ Liquid Embolic May Improve Outcomes in Patients with Chronic Subdural Hematomas
BOSTON, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Balt, Inc., a global technology leader in neurovascular devices, today announced the presentation...
PickleJar Debuts “Win Now” Technology to Simplify Contesting Programs With Strategic Partners and Reward Fans
HOUSTON, TX, Feb. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – PickleJar Entertainment Group, f/k/a NewRegen, Inc. (OTC:NREG) , a...